Inovio’s $71 million deal with The Department of Defense for coronavirus vaccine
Inovio was granted $71 million from the Department of Defense for their vaccine development. The company is also developing needleless devices to inject it.
News and updates on vaccine trials fighting COVID-19
Inovio was granted $71 million from the Department of Defense for their vaccine development. The company is also developing needleless devices to inject it.
Chinese company Clover has begun Phase 1 trials for their coronavirus vaccine.
Moderna is on track to get their vaccine distributed in 2021. With government help, self-manufacturing, and experience, they’ve got a strong chance at it.
Sinovac has reported amazing results regarding their coronavirus vaccine.